Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection

References

• Rickinson AB, Kieff E. Knipe DM, Howley PM. Epstein-Barr virus. Fields Virology 2007; 2:Philadelphia Lippincott Williams & Wilkins 2655 - 2700
   Google Scholar
• Laichalk LL, Thorley-Lawson DA. Terminal differentiation into plasma cells initiated the replicative cycle of Epstein-Barr virus in vivo. J Virol 2005; 79:1296 - 1307
   PubMed Web of Science ®Google Scholar
• Jiang R, Scott RS, Hutt-Fletcher LM. Epstein-Barr virus shed in saliva is high in B cell tropic gp42. J Virol 2006; 80:7281 - 7283
   PubMed Web of Science ®Google Scholar
• Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 2009; 7:10000496
   Google Scholar
• White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 2008; 43:189 - 219
   PubMed Web of Science ®Google Scholar
• Heldwein EE, Lou H, Bender FC, Cohen GH, Eisenberg RJ, Harrison SC. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 2006; 313:217 - 220
   PubMed Web of Science ®Google Scholar
• Atanasiu D, Whitbeck JC, de Leon MP, Lou H, Cohen GH, Eisenberg RJ. Bimolecular complementation defines functional regions of Herpes simplex virus gB that are involved with H/gL as a necessary step leading to fusion. J Virol 2010; 84:3825 - 3834
   PubMed Web of Science ®Google Scholar
• Subramanian RP, Geraghty RJ. Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L and B. Proc Natl Acad Sci USA 2007; 104:2903 - 2908
   PubMed Web of Science ®Google Scholar
• Borza CM, Hutt-Fletcher LM. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nature Med 2002; 8:594 - 599
   PubMed Web of Science ®Google Scholar
• Miller N, Hutt-Fletcher LM. Epstein-Barr virus enters B cells and epithelial cells by different routes. J Virol 1992; 66:3409 - 3414
   PubMed Web of Science ®Google Scholar
• Wu L, Hutt-Fletcher LM. Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion. Virology 2007; 363:148 - 155
   PubMed Web of Science ®Google Scholar
• Wang X, Kenyon WJ, Li QX, Mullberg J, Hutt-Fletcher LM. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J Virol 1998; 72:5552 - 5558
   PubMed Web of Science ®Google Scholar
• Li QX, Spriggs MK, Kovats S, Turk SM, Comeau MR, Nepom B, et al. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 1997; 71:4657 - 4662
   PubMed Web of Science ®Google Scholar
• Kirschner AN, Sorem J, Longnecker R, Jardetzky TS. Structure of Epstein-Barr virus glycoprotein gp42 suggests a mechanism for triggering receptor-activated virus entry. Structure 2009; 17:223 - 233
   PubMed Web of Science ®Google Scholar
• Borza CM, Morgan AJ, Turk SM, Hutt-Fletcher LM. Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J Virol 2004; 78:5007 - 5014
   PubMed Web of Science ®Google Scholar
• Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 2002; 31:485 - 516
   PubMedGoogle Scholar
• Burman A, Clark S, Abrescia NGA, Fry EE, Stuart DI, Jackson T. Specificity of the VP1 GH loop of Foot-and-Mouth Disease Virus for av integrins. J Virol 2006; 80:9798 - 9810
   PubMed Web of Science ®Google Scholar
• Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, et al. The integrin αvβ8 mediates epithelial homeostasis through MT-1-MMP-dependent activation of TGF-β1. J Cell Biol 2002; 157:493 - 507
   PubMed Web of Science ®Google Scholar
• Stewart PL, Nemerow GR. Cell integrins: commonly used receptors for diverse pathogens. Trends Microbiol 2007; 15:500 - 507
   PubMed Web of Science ®Google Scholar
• Xiao J, Palefsky JM, Herrera R, Tugizov SM. Characterization of the Epstein-Barr virus glycoprotein BMRF2. Virology 2007; 359:382 - 396
   PubMed Web of Science ®Google Scholar
• Lee AW, Foo W, Mang O, Sze WM, Chappell R, Lau WH, et al. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980–1999): an encouraging reduction in both incidence and mortality. Int J Cancer 2003; 103:680 - 685
   PubMed Web of Science ®Google Scholar
• Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular prolferation. Cell 1986; 47:883 - 889
   PubMed Web of Science ®Google Scholar
• Moody CA, Scott RS, Su T, Sixbey JW. Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence. J Virol 2003; 77:8555 - 8561
   PubMed Web of Science ®Google Scholar
• Yeung WM, Zong YS, Chiu CT, Sham JS, Choy DT, Ng MH. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 1993; 53:746 - 750
   PubMed Web of Science ®Google Scholar
• Zeng Y, Zhang LG, Wu YC, Huang YS, Huang NQ, Li JY, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer 1985; 36:545 - 547
   PubMed Web of Science ®Google Scholar
• Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12:451 - 462
   PubMed Web of Science ®Google Scholar
• Thomas GJ, Nystrom ML, Marshall JF. αvβ6 integrin in wound healing and cancer of the oral cavity. J Oral Path Med 2006; 35:1 - 10
   PubMed Web of Science ®Google Scholar
• Sheppard D. Integrin-mediated activation of latent transforming growth factor β. Cancer Metastasis Rev 2005; 24:395 - 402
   PubMed Web of Science ®Google Scholar
• Munger JS, Huang X, Kawakatsu H, Griffiths MJD, Garat C, Matthay MA, et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96:319 - 328
   PubMed Web of Science ®Google Scholar
• Liang CL, Chen JL, Hsu YPP, Ou JT, Chang YS. Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-β through cooperativity of Smads and c-Jun/c-Fos proteins. J Biol Chem 2002; 277:23345 - 23357
   PubMed Web of Science ®Google Scholar